# FDA recall Z-1785-2019

> **Randox Laboratories Ltd.** · Class II · device recall initiated 2019-03-11.

## Product

Liquid Cardiac Control, Model Nos. CQ5051, CQ5052, CQ5053

## Reason for recall

Customers may observe a decrease in recovered concentration with regards to NTproBNP in the Liquid Cardiac Control lots identified, on the Siemens Dimension EXL LOCI.

## Distribution

Product distributed to CA, DE, WV, and Puerto Rico.

## Key facts

- **Recall number:** Z-1785-2019
- **Recalling firm:** Randox Laboratories Ltd.
- **Classification:** Class II
- **Product type:** device
- **Status:** Terminated
- **Initiation date:** 2019-03-11
- **Report date:** 2019-06-26
- **Termination date:** 2020-05-15

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Crumlin (North), N/A, Ireland

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1785-2019

## Citation

> AI Analytics. FDA recall Z-1785-2019. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/Z-1785-2019. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*